Literature DB >> 17270591

Diabetes and depression: a review of the literature.

Fredrick Astle1.   

Abstract

Depression affects millions of people in the United States. Drugs used to treat depression can lead to weight gain, which could predispose a person to type 2 diabetes. Also, certain medications that may be used to treat depression with psychotic features can lead to metabolic syndrome and new-onset diabetes. Diabetes is another chronic health care condition that affects millions of people in the United States. Diabetes is the leading cause of nontraumatic amputations and a leading cause of blindness. Both conditions can result in a lower quality of life. Clinicians face challenges in treating either condition, but can face greater ones when the conditions occur together. This article reviews the literature concerning depression and diabetes.

Entities:  

Mesh:

Year:  2007        PMID: 17270591     DOI: 10.1016/j.cnur.2006.11.007

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  5 in total

1.  Diabetes and psychological profile of younger rural African American women with type 2 diabetes.

Authors:  Stephania T Miller
Journal:  J Health Care Poor Underserved       Date:  2011-11

Review 2.  Effects of diabetes on hippocampal neurogenesis: links to cognition and depression.

Authors:  Nancy Ho; Marilyn S Sommers; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2013-05-13       Impact factor: 8.989

3.  Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha.

Authors:  Jennifer M Loftis; Marilyn Huckans; Samantha Ruimy; David J Hinrichs; Peter Hauser
Journal:  Neurosci Lett       Date:  2007-11-06       Impact factor: 3.046

4.  Comorbid depression and risk of lower extremity amputation in people with diabetes: systematic review and meta-analysis.

Authors:  Sinéad M O'Neill; Zubair Kabir; Grace McNamara; Claire Mary Buckley
Journal:  BMJ Open Diabetes Res Care       Date:  2017-08-20

5.  Melatonin-Pretreated Mesenchymal Stem Cells Improved Cognition in a Diabetic Murine Model.

Authors:  Shaimaa Nasr Amin; Nivin Sharawy; Nashwa El Tablawy; Dalia Azmy Elberry; Mira Farouk Youssef; Ebtehal Gamal Abdelhady; Laila Ahmed Rashed; Sherif Sabry Hassan
Journal:  Front Physiol       Date:  2021-03-18       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.